{
  "ptid_time": "137_S_4816_2014-09-17",
  "img_path": "/data/qiuhui/data/adni/images/137_S_4816/2014-09-17/t1.nii.gz",
  "img_finding": "Image findings: hippocampal volume measures 6,745 mm³, 10.8% below the reference mean. With a Z-score of -1.05 (14.7th percentile), this represents mild atrophy; whole brain volume measures 1,220,360 mm³, 13.1% above the reference mean. With a Z-score of 1.70 (95.5th percentile), this represents moderate enlargement. ",
  "text_data": "Age is 76.2 years. Gender is Male. Education: 16 years. MMSE: 25.0. MoCA: 22.0. Logical Memory: 4.0. APOEε4 alleles: 2.0. Biomarker levels: Florbetapir (AV45): 1.47 SUVR (profound elevated); Amyloid beta: 474.90 pg/mL (mild reduced); Total tau: 540.70 pg/mL (profound elevated); Phosphorylated tau: 56.21 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The patient shows mild hippocampal atrophy (Z-score -1.05) but paradoxically has an enlarged whole brain volume (Z-score +1.70). Cognitive scores (MMSE 25, MoCA 22) suggest mild impairment. Biomarkers (Aβ mildly reduced, T-tau/P-tau/AV45 profoundly elevated) strongly indicate Alzheimer’s pathology despite the atypical brain volume findings.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI) due to Alzheimer’s disease**  \n**Confidence:** **Medium** (due to conflicting imaging findings, but biomarker profile is highly suggestive of AD pathology)",
  "timestamp": "2025-07-26T16:44:42.522741"
}